[Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation].
Iriondo
A
A
Richard
C
C
Hermosa
V
V
Conde
E
E
Garijo
J
J
Cuadrado
M A
MA
Bello
C
C
Muruzábal
M J
MJ
Pérez-Encinas
M
M
Zubizarreta
A
A
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008212:Lymphocyte Depletion; D013601:T-Lymphocytes
D000911:Antibodies, Monoclonal
Prevención de la enfermedad injerto contra huésped mediante depleción in vitro de linfocitos T con anticuerpos monoclonales (Campath-1) en pacientes sometidos a trasplante de medula ósea.